Hilo (fka Aktiia), a Neuchatel, Switzerland-based blood pressure intelligence platform provider, raised $42m (over CHF 34m) in Series B funding round.
The round, which brought the total financing to date above $100m, was led by Earlybird Health and Wellington Partners, with new investors Kfund and naturalX Health Ventures, and participation from existing investors redalpine, Khosla Ventures, Molten Ventures, Translink Capital and Verve Ventures. Christoph Massner, Principal at Earlybird Health, will join Hilo’s Board of Directors.
The company intends to use the funds to accelerate product innovation, expand into new markets, and build out its blood pressure intelligence platform to support enterprise use cases.
Led by CEO Raghav Gupta, Hilo provides cuffless blood pressure monitoring (CBPM) products that offer reports to give both individuals and healthcare professionals a useful picture of their blood pressure. The model has been trained on optical signals and readings across more than 120,000 users.
The team, composed of experts with extensive experience in biomedical signal processing, has contributed to over 120 peer-reviewed publications and holds more than 35 patents.
FinSMEs
05/05/2025